Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression (NCT06898424) | Clinical Trial Compass
CompletedNot Applicable
Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression
Turkey (Türkiye)60 participantsStarted 2024-03-01
Plain-language summary
This study investigates the effects of the Ketoflex 12/3 diet on the clinical progression of early-to-mid stage Alzheimer's disease. The study evaluates cognitive function, metabolic changes, and overall health outcomes in participants following the Ketoflex 12/3 dietary protocol.
Who can participate
Age range
50 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 50-85 years
* Clinical Dementia Rating (CDR) score of 1 or2
* Diagnosis of Alzheimer's disease (AD) according to NIA-AA criteria
Exclusion Criteria:
* Alcohol and/or substance dependence
* Diagnosis of chronic renal failure
* Diagnosis of another neuropsychiatric disorder
* Presence of amalgam dental fillings and/or failure to have them removed following the SMART protocol
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested something called the Ketoflex 12/3 diet in people with early-to-mid stage Alzheimer's — can you explain what that diet actually involves, and whether the results from this completed study suggest it might be worth considering alongside my current treatment plan?
2The trial measured cognitive function using the MMSE score — do you know if the results showed any meaningful change in that score, and what that would realistically mean for someone at my stage of the disease?
3Since this is listed as Phase NA, which I understand often applies to behavioral or dietary studies rather than drug trials, does that affect how seriously we should take the findings compared to a standard drug trial?
4The Ketoflex 12/3 approach involves specific eating windows and dietary rules — given my overall health, medications, and any nutritional concerns, is a diet like this something that would even be safe for me to try?
5Are there standard treatments or other completed studies I should consider before pursuing a dietary intervention like this one, especially since this trial is already completed and I wouldn't be enrolling in it?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Cognitive Function as Measured by the MMSE Score